New Issue: Orbital Catastrophe Ahead? Read Now

Nanomedicine Aims New Treatments at Cancer and Dangerous Wounds

Working on a very small scale lets scientists give drugs abilities denied to larger molecules

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


A molecule of DNA, holding its blueprint for life, is about 2.5 billionths of a meter in diameter. Scientists now have the ability to push and pull and build molecules of that size, as well as to create devices that sense them with unprecedented precision. These skills, gained through painstaking work during the past decade, are leading to new medicines and ways of diagnosing disease. In this special report, Scientific American examines what nanomedicine is bringing us now, what is coming soon and what the future will likely hold.

Right now chemotherapy is a major focus, and drugs that can slip into tumors because of their fine-grained construction are showing success where other medications fail patients [see “Cancer Drugs Hit Their Mark,]. Diagnostic tests are also taking advantage of the small sizes, using probes of unusually shaped DNA that can detect cancer with remarkable accuracy. Next, in the near future, patients should be able to use smart bandages made with nano-sized molecules that enhance the healing of severe wounds—or that signal doctors when healing is not happening [see “A Smarter Bandage”]. Further out in time, researchers hope to attach tiny molecular motors to drugs, driving them through the bloodstream to their targets [see “Launch the Nanobots!”]. These are feats of nanoengineering, invisible to the eye, yet they could have an outsize effect on health.

Josh Fischman was formerly senior editor for special projects at Scientific American and covered medicine, biology and science policy. He has written and edited about science and health for Discover, ScienceEarth and U.S. News & World Report. Follow Fischman on Bluesky @jfischman.bsky.social

More by Josh Fischman
Scientific American Magazine Vol 312 Issue 4This article was published with the title “Small Wonders” in Scientific American Magazine Vol. 312 No. 4 (), p. 42
doi:10.1038/scientificamerican0415-42

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe